Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E 2 production in human chondrocytes

International Immunopharmacology

Volumn 12, Issue 2, 2012, Pages 447-452

  Chen, Wei Ping ^a   Wang, Yu Lu ^a   Tang, Jing Li ^a   Hu, Peng Fei ^a   Bao, Jia Peng ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Chondrocyte; Cyclooxygenase; Inducible NO synthase; Morin; Nitric oxide; Prostaglandin E2

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MORIN; NITRIC OXIDE; PROSTAGLANDIN E2;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; FLAVONOIDS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862779593     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.12.024     Document Type: Article

References (39)

1. D. Loeuille, I. Chary-Valckenaere, J. Champigneulle, A.C. Rat, F. Toussaint, and A. Pinzano-Watrin Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity Arthritis Rheum 52 2005 3492 3501
2. M.J. Benito, D.J. Veale, O. FitzGerald, W.B. van den Berg, and B. Bresnihan Synovial tissue inflammation in early and late osteoarthritis Ann Rheum Dis 64 2005 1263 1267
3. T. Aigner, A. Sachse, P.M. Gebhard, and H.I. Roach Osteoarthritis: pathobiology-targets and ways for therapeutic intervention Adv Drug Deliv Rev 58 2006 128 149
4. G.R. Squires, S. Okouneff, M. Ionescu, and A.R. Poole The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis Arthritis Rheum 48 2003 1261 1270
5. J.P. Pelletier, J. Martel-Pelletier, and S.B. Abramson Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets Arthritis Rheum 44 2001 1237 1247
6. M.B. Goldring, and F. Berenbaum The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide Clin Orthop Relat Res 427 Suppl 2004 S37 S46
7. M. Kobayashi, G.R. Squires, A. Mousa, M. Tanzer, D.J. Zukor, and J. Antoniou Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage Arthritis Rheum 52 2005 128 135
8. N. Chabane, N. Zayed, H. Afif, L. Mfuna-Endam, M. Benderdour, and C. Boileau Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes Osteoarthritis Cartilage 16 2008 1267 1274
9. J. Salvatierra, G. Escames, P. Hernandez, J. Cantero, E. Crespo, and J. Leon Cartilage and serum levels of nitric oxide in patients with hip osteoarthritis J Rheumatol 26 1999 2015 2017
10. D. Salvemini, T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie, and P. Needleman Nitric oxide activates cyclooxygenase enzymes Proc Natl Acad Sci U S A 90 1993 7240 7244
11. K. Sasaki, T. Hattori, T. Fujisawa, K. Takahashi, H. Inoue, and M. Takigawa Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes J Biochem 123 1998 431 439
12. G. Dannhardt, and W. Kiefer Cyclooxygenase inhibitors-current status and future prospects Eur J Med Chem 36 2001 109 126
13. C. Miyaura, M. Inada, T. Suzawa, Y. Sugimoto, F. Ushikubi, and A. Ichikawa Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice J Biol Chem 275 2000 19819 19823
14. J.T. Tung, C.E. Arnold, L.H. Alexander, V. Yuzbasiyan-Gurkan, P.J. Venta, and D.W. Richardson Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures Am J Vet Res 63 2002 987 993
15. J. Martel-Pelletier, J.P. Pelletier, and H. Fahmi Cyclooxygenase-2 and prostaglandins in articular tissues Semin Arthritis Rheum 33 2003 155 167
16. J.M. Kim, E.K. Lee, G. Park, M.K. Kim, T. Yokozawa, and B.P. Yu Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity Free Radic Res 44 2010 454 461
17. S. Subash, and P. Subramanian Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study Mol Cell Biochem 327 2009 153 161
18. Sivaramakrishnan V, Devaraj SN. Morin fosters apoptosis in experimental hepatocellular carcinogenesis model. Chem Biol Interact. 2010;183: 284-92.
19. J. Galvez, G. Coelho, M.E. Crespo, T. Cruz, M.E. Rodriguez-Cabezas, and A. Concha Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat Aliment Pharmacol Ther 15 2001 2027 2039
20. O.A. Harasstani, S. Moin, C.L. Tham, C.Y. Liew, N. Ismail, and R. Rajajendram Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells Inflamm Res 59 2010 711 721
21. J.W. Kim, J.H. Lee, B.Y. Hwang, S.H. Mun, and N.Y. Ko Kim do K, et al. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo Biochem Pharmacol 77 2009 1506 1512
22. M.A. Ocete, J. Galvez, M.E. Crespo, T. Cruz, M. Gonzalez, and M.I. Torres Effects of morin on an experimental model of acute colitis in rats Pharmacology 57 1998 261 270
23. R.Y. Au, T.K. Al-Talib, A.Y. Au, P.V. Phan, and C.G. Frondoza Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages Osteoarthritis Cartilage 15 2007 1249 1255
24. I. Scott, A. Midha, U. Rashid, S. Ball, A. Walding, and P. Kerry Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1beta-driven model of joint pathology Osteoarthritis Cartilage 17 2009 790 797
25. H.J. Mankin, H. Dorfman, L. Lippiello, and A. Zarins Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data J Bone Joint Surg Am 53 1971 523 537
26. D.D. Wood, E.J. Ihrie, C.A. Dinarello, and P.L. Cohen Isolation of an interleukin-1-like factor from human joint effusions Arthritis Rheum 26 1983 975 983
27. L.C. Tetlow, D.J. Adlam, and D.E. Woolley Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes Arthritis Rheum 44 2001 585 594
28. J.P. Caron, J.C. Fernandes, J. Martel-Pelletier, G. Tardif, F. Mineau, and C. Geng Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression Arthritis Rheum 39 1996 1535 1544
29. S.H. Fang, Y.C. Hou, W.C. Chang, S.L. Hsiu, P.D. Chao, and B.L. Chiang Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock Life Sci 74 2003 743 756
30. H.S. Lee, K.H. Jung, S.W. Hong, I.S. Park, C. Lee, and H.K. Han Morin protects acute liver damage by carbon tetrachloride (CCl(4)) in rat Arch Pharm Res 31 2008 1160 1165
31. G. Aliev, P. Bodin, and G. Burnstock Free radical generators cause changes in endothelial and inducible nitric oxide synthases and endothelin-1 immunoreactivity in endothelial cells from hyperlipidemic rabbits Mol Genet Metab 63 1998 191 197
32. V. Sivaramakrishnan, and S. Niranjali Devaraj Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma Chem Biol Interact 180 2009 353 359
33. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 2001 7 11
34. S. Ghosh, and D. Baltimore Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B Nature 344 1990 678 682
35. V. Gilston, H.W. Jones, C.C. Soo, A. Coumbe, S. Blades, and C. Kaltschmidt NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation Biochem Soc Trans 25 1997 518S
36. A.V. Miagkov, D.V. Kovalenko, C.E. Brown, J.R. Didsbury, J.P. Cogswell, and S.A. Stimpson NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint Proc Natl Acad Sci U S A 95 1998 13859 13864
37. C. Lianxu, J. Hongti, and Y. Changlong NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes Osteoarthritis Cartilage 14 2006 367 376
38. K.M. Stuhlmeier The anti-rheumatic gold salt aurothiomalate suppresses interleukin-1beta-induced hyaluronan accumulation by blocking HAS1 transcription and by acting as a COX-2 transcriptional repressor J Biol Chem 282 2007 2250 2258
39. S.K. Manna, R.S. Aggarwal, G. Sethi, B.B. Aggarwal, and G.T. Ramesh Morin (3,5,7,2′,4′-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis Clin Cancer Res 13 2007 2290 2297